NM_001114753.3(ENG):c.142C>T (p.Gln48Ter) AND Hereditary hemorrhagic telangiectasia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 25, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001206409.9

Allele description [Variation Report for NM_001114753.3(ENG):c.142C>T (p.Gln48Ter)]

NM_001114753.3(ENG):c.142C>T (p.Gln48Ter)

Gene:
ENG:endoglin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001114753.3(ENG):c.142C>T (p.Gln48Ter)
Other names:
p.Gln48*
HGVS:
  • NC_000009.12:g.127843171G>A
  • NG_009551.1:g.16598C>T
  • NM_000118.4:c.142C>T
  • NM_001114753.3:c.142C>TMANE SELECT
  • NM_001278138.2:c.-405C>T
  • NM_001406715.1:c.142C>T
  • NP_000109.1:p.Gln48Ter
  • NP_000109.1:p.Gln48Ter
  • NP_001108225.1:p.Gln48Ter
  • NP_001108225.1:p.Gln48Ter
  • NP_001393644.1:p.Gln48Ter
  • LRG_589t1:c.142C>T
  • LRG_589t2:c.142C>T
  • LRG_589:g.16598C>T
  • LRG_589p1:p.Gln48Ter
  • LRG_589p2:p.Gln48Ter
  • NC_000009.11:g.130605450G>A
  • NM_000118.3:c.142C>T
  • NM_001114753.2:c.142C>T
Protein change:
Q48*
Links:
dbSNP: rs1831082433
NCBI 1000 Genomes Browser:
rs1831082433
Molecular consequence:
  • NM_001278138.2:c.-405C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000118.4:c.142C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001114753.3:c.142C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001406715.1:c.142C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary hemorrhagic telangiectasia (HHT)
Synonyms:
Osler Weber Rendu syndrome; ORW disease; Osler-Rendu-Weber disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0019180; MedGen: C0039445; OMIM: PS187300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001377717Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 25, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.

Abdalla SA, Letarte M.

J Med Genet. 2006 Feb;43(2):97-110. Epub 2005 May 6. Review.

PubMed [citation]
PMID:
15879500
PMCID:
PMC2603035

The physiological role of endoglin in the cardiovascular system.

López-Novoa JM, Bernabeu C.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H959-74. doi: 10.1152/ajpheart.01251.2009. Epub 2010 Jul 23. Review.

PubMed [citation]
PMID:
20656886
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001377717.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500, 20656886, 22385575). This variant has been observed in an individual affected with hereditary hemorrhagic telangiectasia (PMID: 15517393). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln48*) in the ENG gene. It is expected to result in an absent or disrupted protein product.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024